MariMed Announces Third Quarter 2024 Earnings Date
Rhea-AI Summary
MariMed Inc. (CSE: MRMD, OTCQX: MRMD), a leading multi-state cannabis operator, has announced the date for its third quarter 2024 earnings report. The company will release its financial results on November 6, 2024 after market close. Following the release, MariMed's management will host a conference call on November 7, 2024, at 8:00 a.m. EST to discuss the financial results.
Investors and interested parties can access the webcast through MariMed's Investor Relations website. For those unable to attend the live call, a playback will be made available on the same website. This announcement demonstrates MariMed's commitment to transparency and shareholder communication.
Positive
- Timely scheduling of earnings report and conference call demonstrates transparency
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, MRMD declined 4.46%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
NORWOOD, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, announced today it will report third quarter 2024 financial results on November 6, 2024 after the markets close. Management will host a conference call on November 7, 2024 at 8:00 a.m. EST to discuss financial results.
A webcast will be available and can be accessed via MariMed’s Investor Relations website at MariMed Q324 Earnings Webcast. A playback of the call will also be made available on MariMed’s Investor Relations website.
About MariMed
MariMed Inc. is a leading multi-state cannabis operator, known for developing and managing state-of-the-art cultivation, production, and retail facilities. Our award-winning portfolio of cannabis brands, including Betty's Eddies™, Bubby’s Baked™, Vibations™, InHouse™, and Nature’s Heritage™, sets us apart as an industry leader. These trusted brands, crafted with quality and innovation, are recognized and loved by consumers across the country. With a commitment to excellence, MariMed continues to drive growth and set new standards in the cannabis industry. For additional information, visit www.marimedinc.com.
Investor Relations Contact:
Steve West
Vice President, Investor Relations
Email: ir@marimedinc.com
Phone: (781) 277-0007
Company Contact:
Howard Schacter
Chief Communications Officer
Email: hschacter@marimedinc.com
Phone: (781) 277-0007
FAQ
When will MariMed (MRMD) release its Q3 2024 earnings report?
What is the date and time for MariMed's (MRMD) Q3 2024 earnings conference call?
How can investors access MariMed's (MRMD) Q3 2024 earnings webcast?
Will there be a playback available for MariMed's (MRMD) Q3 2024 earnings call?
